在患有德斯莫普拉金心肌病症的患者中进行静脉动脉移除
Michael Ghannam1, Jackson J Liang1, Jarieke Hoogendoorn2
1Section of Electrophysiology, Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
JACC. Clinical electrophysiology
|January 11, 2024
概括
在患有Desmoplakin (DSP) 心肌病的患者中,心室动脉障碍 (VT) 切除是复杂的,通常需要双心室和上心脏的方法. 虽然出现复发,但大多数患者在重复手术后达到长期无静脉瘤状态.
科学领域:
- 心脏病学 心脏病学
- 遗传学 是一个遗传学.
- 电子生理学 电子生理学
背景情况:
- 德斯莫普拉金 (DSP) 致病变体导致心律失常性心肌病,经常影响两个心室.
- 腹腔动脉冲动 (VT) 移除是一种潜在的治疗方法,但程序细节没有得到充分记录.
研究的目的:
- 报告在患有 DSP 病原变异的患者中进行静脉瘤切除的多中心经验.
- 在这个特定的患者群体中分析静脉管切除的程序特征和结果.
主要方法:
- 在3个国家的6个中心对VT废除的回顾性分析.
- 包括已知DSP致病变体和症状VTs的患者.
- 详细报告患者特征,程序目标 (内心/表心,RV/LV) 和结果.
主要成果:
- 20名患者接受了静脉管切除,其中16人需要进行心表手术.
- 静脉瘤的目标部位是多样化的,包括RV内心,RV上心,LV内心和LV上心.
- 在11名患者中观察到静脉瘤复发,需要在9名患者中重复切除.
- 在20名患者中,有19名患者在经过18个月的中位随访后仍然没有静脉瘤,并考虑了多次手术.
结论:
- 在DSP心肌病症中,静脉管切除通常涉及由于疾病分布的双心室和上心室方法.
- 静脉动脉基质与冠状动脉的接近程度可能会限制切除成功.
- 尽管复发,但重复的切除有助于大多数患者的长期静脉瘤控制.
相关概念视频
Disturbances in Heart Rhythm
961
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
961
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
836
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
836


